Year archive

Everest Medicines Limited — 2023 filings

All 42 regulatory filings released by Everest Medicines Limited (1952) in 2023, sourced directly from the official regulator.

42 Filings

2023 Period

2023 filings (42)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Share Issue/Capital Change	2023-12-06	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF NEW DRUG APPLICATION IN CHINA FOR NEFECON FOR THE TREATMENT OF PRIMARY IMMUNOGLOBULIN A NEPHROPATHY IN ADULTS AT RISK OF DISEASE PROGRESSION Capital/Financing Update	2023-11-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Share Issue/Capital Change	2023-11-06	English
Next Day Disclosure Return Transaction in Own Shares	2023-10-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-06	English
VOLUNTARY ANNOUNCEMENT COLLABORATION AND LICENSE AGREEMENT WITH KEZAR TO DEVELOP AND COMMERCIALIZE ZETOMIPZOMIB IN GREATER CHINA AND OTHER ASIAN MARKETS Capital/Financing Update	2023-09-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-06	English
Notification Letter with Request Form to Non-registered Holders Report Publication Announcement	2023-08-31	English
Notification Letter with Change Request Form to Registered Shareholders Report Publication Announcement	2023-08-31	English
2023 Interim Report Interim / Quarterly Report H1 2023	2023-08-31	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023 Interim / Quarterly Report H1 2023	2023-08-24	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-04	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, 29 JUNE 2023 Declaration of Voting Results & Voting Rights Announcements	2023-06-29	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-06	English
REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 29 JUNE 2023 AGM Information	2023-06-02	English
Notification Letter with Request Form to Non-registered Holders Report Publication Announcement	2023-05-30	English
Notification Letter with Change Request Form to Registered Shareholders Report Publication Announcement	2023-05-30	English
Documents on Display Regulatory Filings	2023-05-30	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 29 JUNE 2023 AGM Information	2023-05-30	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2023-05-30	English
(1) PROPOSED RE-ELECTION OF DIRECTORS (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES (3) PROPOSED RE-APPOINTMENT OF RETIRING AUDITOR (4) 2022 PROPOSED OPTION GRANT AGM Information	2023-05-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Share Issue/Capital Change	2023-05-05	English
Notification Letter with Request Form to Non-registered Holders Report Publication Announcement	2023-04-20	English
Notification Letter with Change Request Form to Registered Shareholders Report Publication Announcement	2023-04-20	English
2022 Environmental, Social and Governance Report Environmental & Social Information	2023-04-20	English
2022 Annual Report Annual Report FY 2022	2023-04-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-11	English
(1) GRANT OF OPTIONS (2) PROPOSED GRANT OF OPTIONS (3) GRANT OF AWARDS (4) NON-EXEMPTED CONNECTED TRANSACTIONS - PROPOSED AWARD GRANT TO CONNECTED PERSONS (5) NON-EXEMPT CONNECTED TRANSACTION - PROPOS Regulatory Filings	2023-04-03	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-03-31	English
RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF OPERATING OFFICER Board/Management Information	2023-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022 Annual Report FY 2022	2023-03-31	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF NEW DRUG APPLICATION IN CHINA FOR XERAVA TM FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULT PATIENTS Regulatory Filings	2023-03-17	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-15	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-03-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-03	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-01-19	English
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF BOARD COMMITTEES Board/Management Information	2023-01-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-06	English